BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31584378)

  • 1. Prediction and Analysis of Hub Genes in Renal Cell Carcinoma based on CFS Gene Selection Method Combined with Adaboost Algorithm.
    Wang Y; Zheng B; Xu M; Cai S; Younseo J; Zhang C; Jiang B
    Med Chem; 2020; 16(5):654-663. PubMed ID: 31584378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.
    Wang L; Lin Y; Yuan Y; Liu F; Sun K
    Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of feature genes of the renal cell carcinoma with DNA microarray.
    Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
    Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
    Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 7. TYROBP as a molecular target in cholangiocarcinoma, renal cancer and abdominal aortic aneurysm.
    Jia W; Chen L; Hou S; Kang C; Deng H
    Medicine (Baltimore); 2024 Jan; 103(1):e36843. PubMed ID: 38181271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes and pathways in renal cell carcinoma through expression profiling data.
    Liu X; Wang J; Sun G
    Kidney Blood Press Res; 2015; 40(3):288-97. PubMed ID: 26043775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways.
    Li W; Zhu W; Che J; Sun W; Liu M; Peng B; Zheng J
    Kidney Blood Press Res; 2013; 37(4-5):506-13. PubMed ID: 24247930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
    Wu F; Wu S; Gou X
    Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
    Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
    Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma.
    Wu P; Xiang T; Wang J; Lv R; Wu G
    FEBS Open Bio; 2020 Dec; 10(12):2588-2604. PubMed ID: 33015999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
    Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
    Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
    Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
    Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome network analysis reveals candidate genes for renal cell carcinoma.
    Zhai W; Xu YF; Liu M; Zheng JH
    J Cancer Res Ther; 2012; 8(1):28-33. PubMed ID: 22531510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential crucial genes associated with carcinogenesis of clear cell renal cell carcinoma.
    Song E; Song W; Ren M; Xing L; Ni W; Li Y; Gong M; Zhao M; Ma X; Zhang X; An R
    J Cell Biochem; 2018 Jul; 119(7):5163-5174. PubMed ID: 29227586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer.
    Liu BX; Huang GJ; Cheng HB
    J Comput Biol; 2019 Nov; 26(11):1262-1277. PubMed ID: 31211595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.